Clinical Trials in Danville, Virginia
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled229 locationsNCT07181109
Recruiting
Phase 3
ZILRETTA in Subjects With Shoulder Osteoarthritis
Glenohumeral Osteoarthritis
Pacira Pharmaceuticals, Inc150 enrolled32 locationsNCT06269705